MRI-Targeted versus Ultrasonography-Guided Biopsy for Suspected Prostate Cancer

Affiliations

¹ From the Division of General Internal Medicine, Massachusetts General Hospital and Harvard Medical School, Boston (M.J.B.); and the Department of Radiology, NYU Langone Health, New York (A.B.R.).

Editorial

Michael J Barry et al. N Engl J Med. 2018.

. 2018 May 10;378(19):1835-1836.

doi: 10.1056/NEJMe1804231.

¹ From the Division of General Internal Medicine, Massachusetts General Hospital and Harvard Medical School, Boston (M.J.B.); and the Department of Radiology, NYU Langone Health, New York (A.B.R.).

No abstract available

Comment on

MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis.
Kasivisvanathan V, Rannikko AS, Borghi M, Panebianco V, Mynderse LA, Vaarala MH, Briganti A, Budäus L, Hellawell G, Hindley RG, Roobol MJ, Eggener S, Ghei M, Villers A, Bladou F, Villeirs GM, Virdi J, Boxler S, Robert G, Singh PB, Venderink W, Hadaschik BA, Ruffion A, Hu JC, Margolis D, Crouzet S, Klotz L, Taneja SS, Pinto P, Gill I, Allen C, Giganti F, Freeman A, Morris S, Punwani S, Williams NR, Brew-Graves C, Deeks J, Takwoingi Y, Emberton M, Moore CM; PRECISION Study Group Collaborators. Kasivisvanathan V, et al. N Engl J Med. 2018 May 10;378(19):1767-1777. doi: 10.1056/NEJMoa1801993. Epub 2018 Mar 18. N Engl J Med. 2018. PMID: 29552975 Free PMC article. Clinical Trial.